Two investment funds holding shares in MedLife sold their stakes, a thing that makes the biggest player on the Romanian health services market of being one step closer to listing on the Bucharest Stock Exchange (BVB).
“MedLife today announced the intention of V4C Eastern Europe Holding V Limited (V4C) and the International Finance Corporation (IFC), member of the World Bank Group, to launch an Initial Public Offering (IPO) of existing ordinary shares in the share capital of the Company, that is intended to take place following the approval of the Prospectus by the Romanian Financial Supervisory Authority. The offering would comprise an offering of up to 8,840,480 existing shares, representing up to 44 percent of the total number of existing shares of the Company,” a press release informs on Tuesday.
MedLife intends to apply for the admission of its shares to trading on the spot regulated market of the Bucharest Stock Exchange following the approval of the Prospectus and the closing of the Offering.
The current shareholding structure of MedLife is: the Marcu family – 51 percent, private equity fund V4C – 36.25005 percent and IFC – 12.74995 percent.
The Marcu family is not selling any shares in the Offering and will remain with 51 percent of the shares at completion. The IFC will hold at least 5 percent of the Company’s shares post completion.V4C intends to fully exit its shareholding.
MedLife notes that will not raise new capital in connection with the public offering and will not receive any of the proceeds. The Offering will be made to institutional and retail investors in Romania and in a private placement to qualified international institutional investors outside the United States.
As at September 30, 2016, MedLife operated 36 clinics, 8 general and specialist hospitals, 24 laboratories with more than 143 sampling points, 9 pharmacies, 8 dental offices and served over a half million HPP (healthcare prevention packages) clients throughout Romania.
During May – July 2016, the Group’s clinics provided services to an average of some 8,300 patients every day and its laboratories conducted over 28,000 tests on average every day.